Home | Welcome to Contract Pharma   
Last Updated Wednesday, November 26 2014
Print

Topics - Drug Development


Refine by Date:
From: To:
Published November 24, 2014
Janssen licenses Transposagen genome editing technologies Read More »
Published November 24, 2014
Safety review finds increased number in deaths in the rilotumumab treatment arm Read More »
Published November 24, 2014
Aims to develop, manufacture, and distribute NewLink's rVSV-EBOV candidate Read More »
Published November 24, 2014
Will evaluate immunotherapies Opdivo and FPA008 in six tumor types Read More »
Published November 21, 2014
Gains rights to promising ophthalmology compound Read More »
Published November 20, 2014
Enrolls first patient in Phase III linaclotide trial Read More »
Published November 20, 2014
Aims to better support customers in the region Read More »
Published November 18, 2014
Alliance of CMO with leading drug product formulator creates fully integrated CDMO focusing on advanced drug delivery and combination products. Read More »
Published November 18, 2014
Aims to identify early-stage opportunities at leading U.S. academic research institutions Read More »
Published November 18, 2014
Issuance of Patent 8,859,530 covers co-administration of steroids and zoledronic acid related to novel investigational therapy for controlling osteoarthritis. Read More »
Published November 17, 2014
Will use Tekmira's LNP delivery technology for Dicerna's PH1 candidate Read More »
Published November 17, 2014
To co-develop and commercialize Merck‚Äôs anti-PD-L1 antibody Read More »
Published November 14, 2014
Lusomedicamenta provides access to new markets Read More »
Published November 14, 2014
Adds global particle size engineering technologies Read More »
Published November 13, 2014
To discover and develop new delivery methods for antisense oligonucleotides Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On